ClinicalTrials.gov
ClinicalTrials.gov Menu

Combined Treatment for Tobacco and Alcohol Use in Puerto Rico

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00570804
Recruitment Status : Active, not recruiting
First Posted : December 11, 2007
Last Update Posted : January 9, 2018
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

Brief Summary:

Objectives:

  1. Assess MAPS and MAPS+ effects on alcohol at-risk behaviors and smoking cessation.
  2. Assess MAPS and MAPS+ effects on treatment mechanisms (increased self-efficacy, decreased temptations/craving, decreased stress and negative affect) and the role of those mechanisms in mediating MAPS and MAPS+ effects on alcohol at-risk behaviors and smoking cessation.
  3. Evaluate the cost-effectiveness of MAPS and MAPS+ in the reduction of at-risk drinking and smoking cessation.

Condition or disease Intervention/treatment Phase
Smoking Behavioral: Telephone Counseling Behavioral: Telephone Assessments Not Applicable

  Show Detailed Description

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 370 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Oral Cancer Risk Reduction Through Combined Treatment for Tobacco and Alcohol Use
Actual Study Start Date : December 2007
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : December 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Alcohol

Arm Intervention/treatment
MAPS+

MAPS+ (Motivation and Problem-Solving Plus):

Counseling using specific treatment approach that focuses on combined smoking cessation and the reduction of at-risk alcohol use.

Behavioral: Telephone Counseling
7 counseling calls where quit date set on first counseling call; then counseling calls on quit date, 3-5 days after quit date, 7-10 days after quit date, 15-30 days after quit date, 45-60 days after quit date, and 90 days after quit date, each taking about 15 to 30 minutes to complete.

Behavioral: Telephone Assessments
4 assessment telephone calls at Weeks 12, 26 and 52 (interview by a research staff member), taking about 30 minutes each to complete.
Other Names:
  • Survey
  • Questionnaire

MAPS

MAPS (Motivation and Problem-Solving):

Counseling treatment approach with a focus on smoking cessation.

Behavioral: Telephone Counseling
7 counseling calls where quit date set on first counseling call; then counseling calls on quit date, 3-5 days after quit date, 7-10 days after quit date, 15-30 days after quit date, 45-60 days after quit date, and 90 days after quit date, each taking about 15 to 30 minutes to complete.

Behavioral: Telephone Assessments
4 assessment telephone calls at Weeks 12, 26 and 52 (interview by a research staff member), taking about 30 minutes each to complete.
Other Names:
  • Survey
  • Questionnaire




Primary Outcome Measures :
  1. Continuous outcome variables (including number of drinks per day, self-efficacy, etc.) [ Time Frame: 2 Years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Current (daily) smoker requesting help for smoking cessation
  2. Exhibit at least one of the following criteria for at-risk drinking: a) an average of =/> 2 alcoholic beverages/day during the past 30 days for men or =/>1 drink/day for women, OR b) two or more occasions of consuming /=> 5 alcoholic beverages during the past 30 days for men or =/>4 drinks for women, OR c) in the past 30 days, driving after consuming =/>3 drinks.
  3. Age 18 or above
  4. Motivated to quit smoking in the next 30 days
  5. Viable (working) telephone number and home address
  6. No other household member enrolled in this protocol
  7. Residing in Puerto Rico
  8. Must score less than or equal to 15 on the AUDIT (Alcohol Use Disorders Identification Test)

Exclusion Criteria:

  1. Currently incarcerated or in jail
  2. Currently pregnant
  3. Score equal to or more than 16 on the Alcohol Use Disorders Identification Test (AUDIT) measure.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00570804


Locations
United States, Texas
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030
Sponsors and Collaborators
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Investigators
Principal Investigator: David Wetter, PhD M.D. Anderson Cancer Center

Additional Information:
Responsible Party: M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier: NCT00570804     History of Changes
Other Study ID Numbers: 2005-0791
U54CA096300 ( U.S. NIH Grant/Contract )
U54CA096297 ( U.S. NIH Grant/Contract )
NCI-2012-02110 ( Registry Identifier: NCI CTRP )
First Posted: December 11, 2007    Key Record Dates
Last Update Posted: January 9, 2018
Last Verified: January 2018

Keywords provided by M.D. Anderson Cancer Center:
Oral Cancer
Smoking Cessation
Puerto Rico Quitline
Motivational Relapse Prevention
Risk Reduction
Tobacco Use
Alcohol Use
MAPS
Motivation and Problem-Solving
Telephone Interview
Counseling

Additional relevant MeSH terms:
Alcohol Drinking
Drinking Behavior
Ethanol
Anti-Infective Agents, Local
Anti-Infective Agents
Central Nervous System Depressants
Physiological Effects of Drugs